Today: 9 June 2026
Rolls-Royce stock: fresh buyback update hits before London open as FY25 results loom
13 January 2026
1 min read

Rolls-Royce stock: fresh buyback update hits before London open as FY25 results loom

London, Jan 13, 2026, 07:59 GMT — Premarket update.

  • Rolls-Royce revealed it purchased 446,323 shares on Jan. 12 as part of its £200 million buyback program.
  • The stock finished down 0.5%, closing at 1,287 pence.
  • The next major catalyst comes with FY25 results due Feb. 26, which investors are already eyeing.

Rolls-Royce Holdings plc revealed it purchased 446,323 shares on Monday under its ongoing £200 million interim share buyback scheme, according to a regulatory filing published early Tuesday.

The flow matters since company news is light this week, making the buyback one of the rare planned demand drivers ahead of earnings.

A share buyback happens when a company buys back its own shares and cancels them, cutting the total share count. Rolls-Royce announced its interim buyback programme will run until Feb. 24, just before its FY25 results are due on Feb. 26. The company also plans to reveal the full 2026 buyback target then.

Rolls-Royce shares ended Monday at 1,287 pence, slipping 0.5%.

On Monday, the company reported that UBS snapped up 324,101 shares on the London Stock Exchange, along with extra blocks traded on CBOE BXE, CBOE CXE, and Aquis. According to the notice, the volume-weighted average prices hovered near 1,295 pence.

The top price reached 1,302 pence, while the lowest stood at 1,287.5 pence. Rolls-Royce confirmed it plans to cancel the shares and holds no shares in treasury following the deal.

Rolls-Royce has bought back 3,151,490 shares since the programme began, paying a weighted average of 1,252.5434 pence each, according to Tuesday’s notice.

With a market value near £108 billion, the £200 million programme might seem modest at first glance. Yet, it delivers a consistent, noticeable trade every day.

In its last update on Monday, the company revealed it purchased 398,806 shares on Jan. 9 at volume-weighted average prices near 1,286 pence, again through UBS using the same trading venues.

The buyback won’t act as a safeguard. A dip in profit or cash flow at the FY25 results, or weaker 2026 guidance, could still weigh on the stock despite ongoing daily repurchases.

Traders are set to track the next daily buyback disclosures once markets open, before turning their attention to the Feb. 24 deadline for the interim programme. The Feb. 26 FY25 results will then provide the next concrete update on capital returns.

Stock Market Today

  • Alibaba Stock Falls 18% Amid Heavy AI Investment
    June 9, 2026, 10:38 AM EDT. Alibaba shares have dropped 18% year-to-date, weighed down by the company's aggressive spending on artificial intelligence (AI) initiatives. This investment strategy has raised concerns among investors about its impact on short-term profitability. The stock's decline outpaces broader market trends and highlights the risks tech giants face when prioritizing long-term innovation over immediate earnings. Analysts note the move reflects Alibaba's commitment to staying competitive in the evolving technology landscape despite near-term challenges.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Tesla stock edges up after hours as robotaxi deadlines, CPI and earnings line up as next tests for TSLA
Previous Story

Tesla stock edges up after hours as robotaxi deadlines, CPI and earnings line up as next tests for TSLA

Locked out of $22B: Canadian real estate funds freeze withdrawals as gates spread
Next Story

Locked out of $22B: Canadian real estate funds freeze withdrawals as gates spread

Go toTop